Bionano Genomics (BNGO) vs Precision Optics (POCI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Precision Optics (POCI) has outperformed Bionano Genomics (BNGO) over the past year, gaining 7.2% versus a loss of 26.3%. Over five years, POCI leads with a -29.3% price change compared with -100.0% for BNGO. Precision Optics is the larger company by market cap ($50.5 million vs $17.2 million), about 2.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BNGO | POCI |
|---|---|---|
| Share price | $1.46 | $4.60 |
| Market cap | $17.19M | $50.47M |
| 1-day change | 0.00% | -1.39% |
| YTD return | -4.58% | +11.34% |
| 1-year return | -26.26% | +7.24% |
| 5-year return | -99.95% | -29.32% |
| Forward P/E | — | 153.33 |
| EPS (TTM) | $-3.02 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.23 | $6.15 |
| 52-week low | $1.00 | $3.55 |
| Distance from 52-week high | -34.53% | -25.20% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +242.47% | +73.91% |
| Average volume | 921.59K | 51.88K |
| Shares outstanding | 11.78M | 10.97M |
| Employees | 95 | 108 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Precision Optics is about 2.9 times larger than Bionano Genomics by market value ($50.47M vs $17.19M).
- POCI has outperformed BNGO by 33.5 percentage points over the past year.
- The two companies sit in different sectors: Bionano Genomics in Industrials and Precision Optics in Health Care.
About Bionano Genomics
BNGO stock →Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.
Industrials · Biotechnology: Laboratory Analytical Instruments · 95 employees
About Precision Optics
POCI stock →Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 108 employees
BNGO vs POCI FAQ
Which is bigger, Bionano Genomics or Precision Optics?
Precision Optics (POCI) is larger, with a market capitalization of $50.47M compared with $17.19M for Bionano Genomics (BNGO).
Which stock has performed better over the past year, BNGO or POCI?
POCI returned +7.24% over the past 12 months, compared with -26.26% for BNGO (price return, excluding dividends). Past performance does not predict future results.
Are Bionano Genomics and Precision Optics in the same industry?
No. Bionano Genomics is in the Industrials sector, while Precision Optics is in Health Care.